PolyPeptide Group

Swiss public CDMO (PPGN.SX). Founded 1952, headquartered in Baar, Switzerland. Operates 6 GMP facilities in Sweden, Belgium, France, USA, and India. Specializes in peptide and oligonucleotide APIs. Claims to manufacture ~50% of commercially approved peptide APIs globally.